Intranasal measles virus– and mumps virus–based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmission

Proceedings of the National Academy of Sciences, Volume 122, number 32, August 2025.
The significant intranasal vaccine offers many unique advantages compared to traditional intramuscular vaccines. Here, we have developed monovalent and trivalent vaccines Omicron XBB.1.5 based on points using the attenuated measles virus (MEV) …